PREVENTION OF HYPONATREMIA AND CEREBRAL EDEMA BY THE VASOPRESSIN ANTAGONIST D/CH2/5TYR/ET/VAVP IN RATS TREATED WITH PITRESSIN TANNATE

被引：18

作者：

LASZLO, FA ^{[1
]}

CSATI, S ^{[1
]}

BALASPIRI, L ^{[1
]}

机构：

[1] UNIV MED SCH SZEGED,DEPT MED CHEM,H-6720 SZEGED,HUNGARY

来源：

ACTA ENDOCRINOLOGICA | 1984年 / 106卷 / 01期

关键词：

D O I：

10.1530/acta.0.1060056

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：56 / 60

页数：5

共 32 条

[11] Analogs of the vasopressin vasodilating peptide d(CH2)5[D-Tyr(Et)2, Arg3]VAVP with strikingly enhanced bypotensive agonism
Stoev, Stoytcho
Cheng, Ling Ling
Manning, Maurice
Wo, Nga C.
Szeto, Hazel H.
[J]. PEPTIDES 2004, PROCEEDINGS: BRIDGES BETWEEN DISCIPLINES, 2005, : 904 - 905
[12] ANALOGS OF THE VASOPRESSIN VASODILATING PEPTIDE D(CH2)5[D-TYR(ET)2,ARG3]VAVP WITH STRIKINGLY ENHANCED HYPOTENSIVE AGONISM
Stoev, S.
Cheng, L. L.
Manning, M.
Wo, N. C.
Szeto, H. H.
[J]. JOURNAL OF PEPTIDE SCIENCE, 2004, 10 : 254 - 254
[13] ANTAGONISM OF VASOPRESSIN-INDUCED CORONARY-ARTERY CONSTRICTION BY THE VASOPRESSIN ANTAGONIST, D(CH2)5TYR(ME)-AVP (SK-AND-F-100273)
VALOCIK, RE
KINTER, LB
KOPIA, GA
[J]. FEDERATION PROCEEDINGS, 1985, 44 (05) : 1480 - 1480
[14] A NOVEL RADIOLABELED VASOPRESSIN ANTAGONIST - [H-3-PHE]-DESGLYD(CH2)5D-TYR(ET)VAVP, [H-3] SK-AND-F-101926
STASSEN, FL
HECKMAN, G
SCHMIDT, D
NAMBI, P
AIYAR, N
LANDVATTER, S
CROOKE, ST
[J]. MOLECULAR PHARMACOLOGY, 1987, 31 (03) : 267 - 272
[15] THE OXYTOCIN ANTAGONIST D(CH2)5TYR(ME)-ORN8-VASOTOCIN INHIBITS MALE COPULATORY-BEHAVIOR IN RATS
ARGIOLAS, A
COLLU, M
GESSA, GL
MELIS, MR
SERRA, G
[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 149 (03) : 389 - 392
[16] APOMORPHINE STIMULATION OF MALE COPULATORY-BEHAVIOR IS PREVENTED BY THE OXYTOCIN ANTAGONIST D(CH2)5TYR(ME)-ORN8-VASOTOCIN IN RATS
ARGIOLAS, A
COLLU, M
DAQUILA, P
GESSA, GL
MELIS, MR
SERRA, G
[J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1989, 33 (01) : 81 - 83
[17] The oxytocin antagonist d(CH2)5Tyr(Me)2-Orn8-vasotocin reduces non-contact penile erections in male rats
Melis, MR
Spano, MS
Succu, S
Argiolas, A
[J]. NEUROSCIENCE LETTERS, 1999, 265 (03) : 171 - 174
[18] NEONATAL TREATMENT WITH VASOPRESSIN ANTAGONIST DP[TYR(ME)2]AVP, BUT NOT WITH VASOPRESSIN ANTAGONIST D(CH2)5[TYR(ME)2]AVP, INHIBITS BODY AND BRAIN-DEVELOPMENT AND INDUCES POLYURIA IN THE RAT
SNIJDEWINT, FGM
BOER, GJ
[J]. NEUROTOXICOLOGY AND TERATOLOGY, 1988, 10 (04) : 321 - 325
[19] THE EFFECT OF VASOPRESSIN ANALOG [D(CH2)(5)(1),TYR(ME)(2)]AVP ON MEMORY PROCESS IN RATS WITH EXPERIMENTAL AMNESIA
CAR, H
BORAWSKA, M
WISNIEWSKI, K
[J]. ACTA NEUROBIOLOGIAE EXPERIMENTALIS, 1995, 55 (03) : 207 - 211
[20] QUANTITATIVE LIGHT MICROSCOPIC AUTORADIOGRAPHIC LOCALIZATION OF BINDING-SITES LABELED WITH [H-3] VASOPRESSIN ANTAGONIST D(CH2)5TYR(ME)VP IN THE RAT-BRAIN, PITUITARY AND KIDNEY
VANLEEUWEN, FW
VANDERBEEK, EM
VANHEERIKHUIZE, JJ
WOLTERS, P
VANDERMEULEN, G
WAN, YP
[J]. NEUROSCIENCE LETTERS, 1987, 80 (02) : 121 - 126

← 1 2 3 4 →